Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China flag China · Delayed Price · Currency is CNY
68.28
-0.95 (-1.37%)
Feb 13, 2026, 3:00 PM CST

Hangzhou Alltest Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
5,3474,9095,3625,5196,631-
Market Cap Growth
1.19%-8.43%-2.86%-16.76%--
Enterprise Value
2,8962,2592,6482,0034,130-
Last Close Price
68.2861.0062.7558.2866.65-
PE Ratio
18.3616.2329.694.668.66-
PS Ratio
6.065.677.101.633.54-
PB Ratio
1.371.261.401.322.03-
P/TBV Ratio
1.421.301.441.362.04-
P/FCF Ratio
106.2345.10-5.068.46-
P/OCF Ratio
21.2014.90216.514.067.18-
EV/Sales Ratio
3.282.613.510.592.21-
EV/EBITDA Ratio
10.708.4822.031.454.88-
EV/EBIT Ratio
12.339.3926.741.484.93-
EV/FCF Ratio
57.5420.75-1.845.27-
Debt / Equity Ratio
0.000.000.010.010.01-
Debt / EBITDA Ratio
0.030.020.170.020.04-
Debt / FCF Ratio
0.160.04-0.020.05-
Net Debt / Equity Ratio
-0.63-0.66-0.72-0.91-0.89-0.72
Net Debt / EBITDA Ratio
-9.27-9.66-23.01-2.75-3.45-0.87
Net Debt / FCF Ratio
-48.69-23.645.44-3.48-3.73-1.20
Asset Turnover
0.210.210.170.780.731.53
Inventory Turnover
2.382.251.995.413.332.29
Quick Ratio
7.989.0610.577.764.534.86
Current Ratio
8.889.9111.538.205.145.75
Return on Equity (ROE)
7.58%7.85%4.51%31.85%36.06%107.31%
Return on Assets (ROA)
3.49%3.62%1.41%19.45%20.29%67.66%
Return on Invested Capital (ROIC)
13.95%17.64%12.52%318.80%216.75%313.21%
Return on Capital Employed (ROCE)
6.00%6.20%2.60%32.40%25.40%82.60%
Earnings Yield
5.51%6.16%3.37%21.47%11.55%-
FCF Yield
0.94%2.22%-9.49%19.76%11.82%-
Dividend Yield
2.93%4.92%2.39%11.59%4.06%-
Payout Ratio
79.11%76.92%292.78%18.20%14.08%-
Buyback Yield / Dilution
-0.08%0.02%0.07%-5.96%-25.16%0.10%
Total Shareholder Return
2.81%4.94%2.46%5.63%-21.10%0.10%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.